QPAC Pharma Consulting SRL
QPAC Pharma Consulting reported total assets of 144,776 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jan 2026).
The score of QPAC Pharma Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
QPAC Pharma Consulting's annual accounts
| 2025 | |
|---|---|
| Net result | 45,346 € |
| Equity | 48,346 € |
| Cash | 33,564 € |
| EBITDA | 80,442 € |
| Total assets | 144,776 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 30 Jan 2026
QPAC Pharma Consulting's financial analysis
- Solvency33.4%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of QPAC Pharma Consulting
QPAC Pharma Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1009.225.612
- VAT number
- BE1009225612
- Peppol
- Registered · 0208:1009225612 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 May 2024
- Registered office
- 2220 Heist-op-den-Berg
- Latest accounts
- 2025 · filed on 30 Jan 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
QPAC Pharma Consulting (SRL) has been based in Heist-op-den-Berg since 2024, active in: business and other management consultancy activities. For 2025, it reports a net profit of 45,346 € and equity of 48,346 €; its revenue is not published. Its solvency stands at 33.4%, below the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to QPAC Pharma Consulting
Companies in the same business, of comparable size and area, outside its group.
- XV Management Business and other management consultancy activities Blegny · balance sheet 144,662 €
- Brussels North Manhattan Centre Business and other management consultancy activities Brussels · balance sheet 144,902 €
- Develops Business and other management consultancy activities Brakel · balance sheet 144,904 €
- DF Industries Business and other management consultancy activities Evergem · balance sheet 144,937 €
- DKF-Trans Business and other management consultancy activities Zandhoven · balance sheet 144,958 €
- S.Dautzenberg Business and other management consultancy activities Oudsbergen · balance sheet 144,567 €
- Peske Business and other management consultancy activities Leopoldsburg · balance sheet 188,681 €
- Executive Transition Management Business and other management consultancy activities Brussels · balance sheet 144,561 €
Frequently asked questions about QPAC Pharma Consulting
What is the revenue of QPAC Pharma Consulting?
QPAC Pharma Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of QPAC Pharma Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE1009225612 for QPAC Pharma Consulting, if the company is VAT-registered. Its company number (CBE) is 1009.225.612.
Where is the registered office of QPAC Pharma Consulting?
According to the CBE register, the registered office of QPAC Pharma Consulting is in 2220 Heist-op-den-Berg.
What is the equity of QPAC Pharma Consulting?
At the close of the 2025 financial year, the equity of QPAC Pharma Consulting amounts to 48,346 €, a solvency of 33.4% of total assets.
Who manages QPAC Pharma Consulting?
The register lists 1 active mandates at QPAC Pharma Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of QPAC Pharma Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →